Mitochondrial fatty acid oxidation disorders in Thai infants: a report of 3 cases

Insights

This report details three infant cases of fatty acid oxidation disorders, including carnitine/acylcarnitine translocase deficiency, medium chain acyl CoA dehydrogenase deficiency, and systemic primary carnitine deficiency. Early diagnosis and intervention are crucial for managing these severe metabolic conditions.

Area of Science:

  • Biochemistry
  • Genetics
  • Pediatrics

Background:

  • Mitochondrial fatty acid oxidation disorders (FAODs) are a group of inherited metabolic diseases.
  • These disorders impair the body's ability to break down fatty acids for energy, leading to severe health problems, especially in infants.

Observation:

  • Case 1: A male infant with carnitine/acylcarnitine translocase deficiency (CACT) presented with cardiac arrest, hypoglycemia, and metabolic acidosis, showing elevated palmitoylcarnitine.
  • Case 2: A male infant with medium chain acyl CoA dehydrogenase (MCAD) deficiency experienced cardiac arrest after a viral illness, with characteristic urine organic acid findings.
  • Case 3: A female infant with systemic primary carnitine deficiency (CDSP) exhibited dilated cardiomyopathy, hepatomegaly, and hypotonia, with extremely low carnitine levels.

Findings:

  • Tandem mass spectrometry and gas liquid chromatography-mass spectrometry are key diagnostic tools for identifying specific FAODs.
  • Elevated acylcarnitine levels (e.g., palmitoylcarnitine) and abnormal urine organic acids are indicative of specific deficiencies.
  • Systemic primary carnitine deficiency can present with cardiomyopathy and hypotonia without hypoglycemia.

Implications:

  • Early detection of FAODs through newborn screening and biochemical testing is vital for timely management.
  • Understanding the specific biochemical profiles associated with each FAOD aids in accurate diagnosis and prognosis.
  • Genetic counseling and family screening are important due to the inherited nature of these disorders.